Page last updated: 2024-11-04

sibutramine and Hypopituitarism

sibutramine has been researched along with Hypopituitarism in 2 studies

sibutramine: serotonin and norepinephrine transporter inhibitor; Meridia is tradename for sibutramine hydrochloride

Hypopituitarism: Diminution or cessation of secretion of one or more hormones from the anterior pituitary gland (including LH; FOLLICLE STIMULATING HORMONE; SOMATOTROPIN; and CORTICOTROPIN). This may result from surgical or radiation ablation, non-secretory PITUITARY NEOPLASMS, metastatic tumors, infarction, PITUITARY APOPLEXY, infiltrative or granulomatous processes, and other conditions.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arango, C1
Rojas, MJ1
Moreno, D1
Parellada, M1
Mersebach, H1
Klose, M1
Svendsen, OL1
Astrup, A1
Feldt-Rasmussen, U1

Other Studies

2 other studies available for sibutramine and Hypopituitarism

ArticleYear
Sibutramine for compulsive eating in hypothalamic deficiency.
    Journal of the American Academy of Child and Adolescent Psychiatry, 2002, Volume: 41, Issue:10

    Topics: Adolescent; Appetite Depressants; Cyclobutanes; Humans; Hyperphagia; Hypopituitarism; Male

2002
Combined dietary and pharmacological weight management in obese hypopituitary patients.
    Obesity research, 2004, Volume: 12, Issue:11

    Topics: Adult; Anthropometry; Appetite Depressants; Blood Glucose; Body Composition; Cholesterol; Combined M

2004